entertainment -WSS

entertainment

author：leisure time 2025-09-03 14:42:43 - browse：38

Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation. — Suzanne Kreiter/Globe staff

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Republican states more likely to report Covid vaccine side effects

WSS

Congress might make insulin pumps more accessible to the blind

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Why don't Americans have at

Study gives hint on South Asians’ higher risk of cardiovascular disease

Trial using CRISPR to edit HIV out of cells disappoints

Artificial intelligence use in health care faces greater scrutiny in 2024

explore

entertainment

focus

Alkermes shareholders re

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Heart attack and stroke risk calculators need revising

Study gives hint on South Asians’ higher risk of cardiovascular disease

State Dept. review finds Biden bears some blame for Afghanistan failures

Overprescribed: High cost isn't America's only drug problem

Novavax promises a turnaround & Lilly roils the obesity market

Artificial intelligence use in health care faces greater scrutiny in 2024

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pancreatic cancer is often deadly, but new discoveries are raising hope

focus

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Four alarming medical procedures we’re glad history forgot

Latigo launches with $135 million for Vertex

Scientists uncover potential path to treating deadly childhood tumor

Congress might make insulin pumps more accessible to the blind

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

entertainment

knowledge

entertainment

focus